Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Deller Sigrid |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Svehlikova, E; Arfelt, KN; Cailleteau, R; Deller, S; Thomsen, KMD; Hart, M; Mursic, I; Pieber, TR; Haahr, H
Hypoglycaemia frequency and physiological response to double or triple doses of once weekly insulin icodec vs. once-daily insulin glargine U100 in type 2 diabetes
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):262-263.-50. ÖDG Jahrestagung; NOV 17-19, 2022; Salzburg, Austria.
[Poster]
Web of Science
SVEHLIKOVA, E; NISS ARFELT, K; CAILLETEAU, R; DELLER, S; THOMSEN, KM; HART, M; MURSIC, I; PIEBER, TR; HAAHR, H
216-OR: Hypoglycemia Frequency and Physiological Response to Double or Triple Doses of Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine in T2D
Diabetes. 2022; Vol 71(Sup 1):216-OR--82nd ADA Scientific Session; JUN 3-7, 2022; New Orleans, USA.
[Oral Communication]
FullText
Brunner, M.; Korsatko, S.; Deller, S.; Kojzar H.; Wolf M.; Urschitz M.; Roepstorff C.; Svendsen A.L.; Haahr H.; Pieber T.R.
Prandiale und basale pharmakodynamische Eigenschaften von Insulin IDegAsp bei jungen und älteren Probandnnen mit Typ 1 Diabetes sind vergleichbar.
Wiener Klinische Wochenschrift. 2013; 125(21-22):19-19.-41. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 21 - 23, 2013; Salzburg, AUSTRIA.
[Poster]
Pieber R.T.; Deller S.; Brunner M.; Jensen L.; Christiansen E.; Kiyomi F.; Heller S.R.
Effects of Liraglutide as Adjunct to Insulin on Counterregulatory Hormone Responses to Hypoglycemia in Type 1 Diabetes: A Randomized, Double-blind, Crossover Trial.
Diabetes. 2013; 62(S1):-American Diabetes Associations 73rd Scientific Sessions, ADA; JUN 21-25, 2013; Chicago, USA.
[Poster]
Pieber, TR; Deller, S; Brunner, M; Jensen, L; Christiansen, E; Kiyomi, F; Heller, SR
Treatment with liraglutide as adjunct to insulin in type 1 diabetes; effects on counter regulatory response to hypoglycaemia: a randomised, double blind, crossover trial
DIABETOLOGIA. . 2013; 56: S404-S405.-49th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 23-27, 2013; Barcelona, SPAIN.
[Poster]
Web of Science
Pieber, TR; Korsatko, S; Deller, S; Kojzar, H; Roepstroff, C; Haahr, H; Svendsen, AL;
The distinct prandial and basal pharmacodynamics of IDegAsp observed in younger adults are preserved in elderly subjects with type 1 diabetes
Diabetes. 2013. 2013; 62(S1): -73rd Scientific Sessions of the American Diabetes Association (ADA); JUN 21-25; Chicago, USA.
[Poster]
Schaller-Ammann, R; Greiner, H; Huber, A; O'Connell, M; Krejci, J; Porro, G; Korsatko, S; Gurban, J; Deller, S; Brunner, M; Berghofer, A; Priedl, J; Zijlstra, E; Heise, T; Pieber, TR; Schaupp, L;
CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEM USING INTRAVENOUS MICRODIALYSIS AND GLUCOSE SENSING.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A72-A72. NEW ROCHELLE: MARY ANN LIEBERT INC;
[Poster]
Web of Science
Urschitz M.; Korsatko S.; Deller S.; Gurban J.; Wolf M.; Brunner M.; Heller S.R.; Jensen L.; Kiyom F.; Christiansen E.; Pieber T.R.
Liraglutide in Kombination mit Insulin bei Typ-1-Diabetes: glykämischer Effekt und Sicherheit in einer randomisierten, doppelblinden Crossover-Studie.
Wiener Klinische Wochenschrift. 2013; 125(21-22):14-14.-41. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 21-23, 2013; Salzburg, AUSTRIA.
[Oral Communication]
Heller, SR; Pieber, TR; Korsatko, S; Köhler, G; Deller, S; Bock, G; Zahiragic, S; Mader, J; Roepstorff, C; Rasmussen, S; Haahr, H
A higher counter-regulatory hormone response is seen with insulin degludec than insulin glargine in response to induced hypoglycaemia in type 1 diabetes.
55th Annual meeting of the Japanese Diabetes Society (JDS); MAY 17-19, 2012; Yokohama, JAPAN. 2012.
[Poster]
Korsatko, S; Deller, S; Mader, J; Glettler, K; Köhler, G; Bock, G; Urschitz, M; Wolf, M; Hastrup, H; Sondergaard, F; Haahr, H; Pieber, TR.
Ultralange, pharmakokinetische und pharmakodynamische Eigenschaften von Insulin Degludec bei jungen und älteren ProbandInnen mit Typ 1 Diabetes sind vergleichbar.
Wiener klinische Wochenschrift. 2012; 124(Sup. 1):8-9.-40. Jahrestagung der Österreichischen Diabetesgeselleschaft; NOV 15-17, 2012; Salzburg, AUSTRIA.
[Oral Communication]
Korsatko, S; Deller, S; Mader, J; Glettler, K; Köhler, G; Bock, G; Urschitz, M; Wolf, M; Hastrup-Nielsen, H; Søndergaard, F; Haahr, HL; Pieber, TR
Ultra-long pharmacokinetic properties of insulin degludec in younger adults are preserved in geriatric subjects with type 1 diabetes.
Diabetologia. 2012; 55(S1):379-380.-48th Annual Meeting of the European Association for the Study of Diabetes (EASD); OCT 1-5, 2012; Berlin, GERMANY.
[Poster]
Korsatko, S; Deller, S; Mader, JK; Glettler, K; Koehler, G; Bock, G; Urschitz, M; Wolf, M; Hastrup, H; Sondergaard, F; Haahr, HL; Pieber, TR.
Ultra-long pharmacokinetic properties of insulin degludec in younger adults preserved in geriatric subjects with T1DM.
Konferenzband. 2012; -9th IDF-WPR (International Diabetes Federation West Pacific Region) Congress & 4th AASD Scientific Meeting; NOV 24-27, 2012; Kyoto, JAPAN.
[Poster]
Korsato, S; Deller, S; Mader, J; Glettler, K; Köhler, G; Bock, G; Urschitz, M; Wolf, M; Hastrup-Nieslen, H; Sondergaard, F; Haahr, H; Pieber, T.
Ultra-long pharmacokinetic properties of insulin degludec in younger adults are preserved in geriatric subjects with type 1 diabetes
Poster & Oral Presentation Guide and Abstract Book. 2012; A259-A259.-American Association of Clinical Endocrinologists 21st Annual Scientific and Clinical Congress; MAY 23-27, 2012; Philadelphia, USA.
[Oral Communication]
Mader, J; Birngruber, T; Deller S; Korsatko, S; Boysen, S; Mautner, S; Augustin, T; Sinner, F; Pieber, TR.
Verbesserte pharmakodynamische Eigenschaften von Insulin aspart durch eine veränderte Applikationsmethode bei Patienten mit Typ 1 Diabetes
Wiener klinische Wochenschrift. 2012; 124(Sup. 1):17-18.-40. Jahrestagung der Österreichischen Diabetesgeselleschaft; NOV 15-17, 2012; Salzburg, AUSTRIA.
[Poster]
Mader, JK; Birngruber, T; Deller, S; Korsatko, S; Boysen, S; Mautner, S; Augustin, T; Pieber, TR
Enhanced pharmacodynamic properties of insulin aspart due to a modified injection strategy in subjects with type 1 diabetes.
Diabetes Care, Supplement 2 . 2012; -72nd Scientific Sessions of the ADA (American Diabetes Association); JUN 8-12, 2012; Philadelphia, USA.
[Poster]
Mader, JK; Birngruber, T; Deller, S; Korsatko, S; Boysen, S; Mautner, S; Augustin, T; Pieber, TR
Enhanced pharmacodynamic properties of insulin aspart due to a modified injection strategy in subjects with type 1 diabetes.
Proceedings of the 72 Scientific Sessions of the American Diabetes Association. 2012; A233-A233.-72nd Scientific Sessions of the ADA (American Diabetes Association); JUN 8-12, 2012; Philadelphia, USA.
[Poster]
Schaupp, L; Schaller-Ammann, R; Huber, A; Korsatko, S; Deller, S; Brunner, M; Berghofer, A; O'Connell, M; Zijlstra, E; Heise, T; Pieber, T
Continuous blood glucose monitoring by combining intravenous microdialysis and ionic reference technique.
Program of the 5th International Conference on Advanced technologies & Treatments for Diabetes. 2012; -The 5th International Conference on Advanced technologies & Treatments for Diabetes; FEB 8-11, 2012; Barcelona, Spain.
[Oral Communication]
Deller, S; Neubauer, K; Korsatko, S; Wolf, M; Urschitz, M; Zahiragic, S; Mader, J; Adrian, C; Thomsen, H; Haahr, H; Pieber, T
Ultra-Long-acting insulin Degludec: Two different concentrations (U100 and U200) showing bioequivalence and comparable pharmacodynamics
WIEN KLIN WOCHENSCHR. . 2011; 123: S10-S11.-39. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 17-19, 2011; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
Heller, SR; Pieber, TR; Korsatko, S; Köhler, G; Deller, S; Bock, G; Zahiragic, S; Mader, JK; Roepstorff; C; Rasmussen, S; Haahr,H;
A higher counter-regulatory hormone response is seen with insulin degludec than insulin glargine in response to induced hypoglycaemia in type 1 diabetes
Diabetologia. 2011; -47th Annual Meeting of EASD; SEP 12-16, 2011; Lisbon, PORTUGAL.
[Poster]
Kohler, G; Korsatko, S; Deller, S; Neubauer, K; Bock, G; Mader, J; Roepstorff, C; Rasmussen, S; Haahr, H; Pieber, T; Heller, S
Induced hypoglycemia in type 1 diabetes with insulin Degludev and Insulin Glargine
WIEN KLIN WOCHENSCHR. 2011; 123: S9-S9.-ÖDG; NOV 17-19, 2011; Salzburg, Austria.
[Oral Communication]
Web of Science
Köhler, G; Korsatko, S; Deller, S; Neubauer, K; Bock, G; Mader, J; Roepstorff, C; Rasmussen, S; Haahr, H; Pieber, TR; Heller, S
Induzierte Hypoglykämie bei Typ 1 Diabetikern mit Insulin Degludec und Insulin Glargin
Konferenzband. 2011; -39. Jahrestagung der ÖDG; NOV 17-19,2011; Salzburg, AUSTRIA.
[Oral Communication]
Korsatko, S; Deller, S; Zahiragic, S; Mader, JK; Neubauer, K; Adrian, C; Thomsen, H; Haahr, H; Pieber, TR
Ultra-long-acting Insulin degludec: two different formulations (U100 and U200) are bioequivalent and show similar pharmacodynamics
Diabetes Care. 2011; -71st Scientific Sessions ADA; 2011; Maryland, USA.
[Poster]
Korsatko, S; Deller, S; Zahiragic, S; Mader, JK; Neubauer, K; Adrian, C; Thomsen, H; Haahr, H; Pieber TR
Ultra-long-acting insulin degludec: bioequivalence and similar pharmacodynamics shown for two different formulations (U100 and U200)
Konferenzband. 2011; -World Diabetes Congress - International Diabetes Federation; 2011; Dubai.
[Poster]
Korsatko, S; Deller, S; Zahiragic, S; Mader, JK; Neubauer, K; Adrian, C; Thomsen, H; Haahr, H; Pieber, TR
Ultra-long-acting insulin degludec: bioequivalence and similar pharmacodynamics shown for two different formulations (U100 and U200)
Diabetologia. 2011; -47th EASD Annual meeting; 2001; Lissabon, PORTUGAL.
[Poster]
PIEBER, T; KORSATKO, S; KÖHLER, G; DELLER, S; BOCK, G; ZAHIRAGIC, S; MADER, J; ROEPSTORFF, C; RASMUSSEN, S; HAAHR, H; HELLER, S;
Response to Induced Hypoglycemia in Type 1 Diabetes: Insulin Degludec Elicits an Enhanced Counter-Regulatory Hormone Response Compared to Insulin Glargine
Diabetes. 2011; -71st Scientific Sessions of ADA; JUN 24-28, 2011; San Diego, USA.
[Poster]
Pieber, TR; Korsatko, S; Koehler, G; Deller, S; Bock, G; Zahiragic, S; Mader, JK; Roepstorff, C; Rasmussen, S; Haahr, H; Heller, S
Induced hypoglycemia in type 1 diabetes: enhanced counter-regulatrory hormone response with insulin degludec versus insulin glargine
Konferenzband. 2011; -World Diabetes Congress- International Diabetes Federation; 2011; Dubai.
[Poster]
Pieber, TR; Korsatko, S; Koehler, G; Deller, S; Bock, G; Zahiragic, S; Mader, JK; Roepstorff, C; Rasmussen, S; Haahr, H; Heller, S
Response to induced hypoglycemia in type 1 diabetes: Insulin degludec elicits an enhanced counter-regulatrory hormone response compared to insulin glargine
Konferenzband. 2011; -14th Professional Congress and Annual Meeting - Canadian Diabetes Association; 2011; Toronot, KANADA.
[Poster]
Mascher, F; Deller, S
Die Nutzung des Sonnenlichts zur Desinfektion von Trinkwasser in den Tropen.
Abstractband. 2004; -Jahrestagung der ÖGTP; Mai 7-8; Wien.
[Oral Communication]
Deller, S; Mascher, F; Platzer, S; Pichler-Semmelrock, FP; Marth, E;
Influence of turbidity, depth of water and use of polyethylene terephtalate bottles on inactivation of the bacterium Escherichia coli in water by solar radiation.
Procceedings. 2003; -2nd International Conference of Ultraviolet Technologies; Jul 9-11; Vienna, Austria.
[Oral Communication]
Mascher, F; Deller, S; Pichler-Semmelrock, FP; Marth E;
Epidemiologische Untersuchungen von öffentlichen Kleinbadeteichen: Eintrag und Verhalten von Indikatorbakterien.
Tagungsband. 2003; -2. Internationaler Kongress für naturnahe Badegewässer.; sep 7-9; Salzburg, Austria.
[Keynote lecture]
Mascher, F; Deller, S; Pichler-Semmelrock, FP; Röhm, S; Marth, E;
Die Bedeutung des Sonnenlichtes für die Reduktion von Indikatorbakterien in Badegewässern.
Tagungsband. 2002; -28. Jahrestagung der ÖGHMP; Mai 7-10; Meran, Italien.
[Oral Communication]